Published in Lancet on August 10, 1974
A study of the sources of delay in the diagnosis and treatment of undescended testicle. J R Coll Gen Pract (1984) 1.18
Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br J Cancer (1976) 0.88
Gonadal function in young adults after surgical treatment of cryptorchidism. Br Med J (1976) 0.87
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2009) 4.58
Hyperprolactinaemia and impotence. Clin Endocrinol (Oxf) (1978) 2.91
Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet (1990) 2.87
Tests of hypothalamic-pituitary-adrenal function in man. Q J Med (1969) 2.41
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) (2001) 2.16
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil Steril (2000) 2.08
Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet (1992) 2.01
Mathematical analysis of kinetics of radioligand assays: improved sensitivity obtained by delayed addition of labeled ligand. J Clin Endocrinol Metab (1971) 1.86
Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis. Lancet (1972) 1.82
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod (1995) 1.75
Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet (1984) 1.71
Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol (1995) 1.71
Kallmann's syndrome: is it always for life? Clin Endocrinol (Oxf) (1999) 1.68
c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies. J Nucl Med (1992) 1.67
Management of hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol (1977) 1.65
Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) (1975) 1.61
Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. Br J Obstet Gynaecol (1993) 1.57
Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril (1996) 1.56
Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril (1994) 1.55
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol (Oxf) (1993) 1.51
Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) (1989) 1.48
A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil Steril (1994) 1.46
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol (1998) 1.43
The treatment of acromegaly with special reference to trans-sphenoidal hypophysectomy. Q J Med (1975) 1.40
Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) (1976) 1.40
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy. Clin Endocrinol (Oxf) (1996) 1.40
Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril (1992) 1.40
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod (1993) 1.33
Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata. Br J Cancer (1973) 1.30
Radioimmunoassay and saturation analysis. Pituitary and placental glycopeptide hormones. Br Med Bull (1974) 1.27
Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol (2003) 1.26
Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf) (1988) 1.25
Characterization of idiopathic premature ovarian failure. Fertil Steril (1996) 1.24
Outcome of pregnancy in underweight women after spontaneous and induced ovulation. Br Med J (Clin Res Ed) (1988) 1.22
Plasma 11-hydroxycorticosteroid and growth hormone levels in acute medical illnesses. Br Med J (1969) 1.21
Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod (1998) 1.21
The treatment of adult enuresis and urge incontinence by enterocystoplasty. Br J Urol (1982) 1.21
Post-"pill" amenorrhoea--cause or coincidence? Br Med J (1977) 1.15
Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod (1993) 1.14
Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child (1985) 1.13
The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril (1992) 1.12
Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. Q J Med (1992) 1.11
Bone mineral loss in young women with amenorrhoea. BMJ (1990) 1.11
A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization. Fertil Steril (1992) 1.09
Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers. Br J Cancer (1973) 1.08
In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod (1992) 1.08
Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure. Br J Obstet Gynaecol (1979) 1.07
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.07
Amenorrhoea and loss of weight. Br J Obstet Gynaecol (1977) 1.07
The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) (1990) 1.06
Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet (1978) 1.06
Investigation and treatment of amenorrhoea resulting in normal fertility. Br Med J (1979) 1.05
Induction of puberty by pulsatile gonadotropin releasing hormone. Lancet (1987) 1.05
Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer (2000) 1.02
Therapy-orientated diagnosis of secondary amenorrhoea. Horm Res (1975) 1.02
A miniature infuser for the pulsatile administration of LHRH. J Biomed Eng (1984) 1.02
Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril (1991) 1.02
Coronary heart disease in relation to age, sex, and the menopause. Br Med J (1978) 1.02
Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) (1978) 1.02
Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril (1993) 1.01
Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril (1990) 1.01
Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression. Anticancer Res (2001) 1.01
Prolactin concentrations in patients with breast cancer. Br Med J (1974) 1.01
Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ (1988) 1.01
Prescribing in general practice: pharmacological approach. Br Med J (Clin Res Ed) (1983) 1.00
Osteopenia as a feature of the androgen insensitivity syndrome. Clin Endocrinol (Oxf) (1995) 1.00
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod (1998) 0.99
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2000) 0.99
For and against: The male menopause--does it exist? BMJ (2000) 0.99
Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) (1988) 0.98
Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol (1994) 0.98
Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol (2001) 0.96
The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer (1991) 0.96
Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome. Fertil Steril (1988) 0.96
The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth (2006) 0.96
Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery. Clin Endocrinol (Oxf) (1976) 0.95
Recent advances in the management of patients with amenorrhoea. Clin Obstet Gynaecol (1985) 0.94
Acute phase reactant proteins in prostatic cancer. Br J Urol (1977) 0.93
Serum LH and FSH during sexual maturation in the male rat: effect of castration and cryptorchidism. Endocrinology (1971) 0.93
Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J (1989) 0.93
Effect of treatment on established osteoporosis in young women with amenorrhoea. Clin Endocrinol (Oxf) (1994) 0.93
Phantom pain: natural history and association with rehabilitation. Ann R Coll Surg Engl (1994) 0.93
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. Br J Cancer (1993) 0.93
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res (1994) 0.93
A toxicity study of the treatment of T3 bladder tumours with a combination of radiotherapy and chemotherapy. Br J Urol (1977) 0.92
Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1996) 0.92
Specific control of follicle stimulating hormone in the male: postulated site of action of inhibin. Clin Endocrinol (Oxf) (1975) 0.92
Amenorrhoea in cystic fibrosis. Clin Endocrinol (Oxf) (1987) 0.92
Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment of overall and age-specific success rates? Br J Obstet Gynaecol (1999) 0.91
Gonadotrophin control of follicular development. Clin Endocrinol (Oxf) (1985) 0.91
Use of activated charcoal in the radioimmunoassay of human growth hormone in plasma. J Clin Pathol (1969) 0.91
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer. Br J Cancer (1996) 0.90
Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil Steril (1991) 0.90